Patents by Inventor Gabriel T. Virella

Gabriel T. Virella has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8911958
    Abstract: The present invention relates to the analysis of modified LDL in the context of immune complexes. In particular, ox-LDL and AGE-LDL are shown to predict the development of coronary artery disease and other micro- and macrovascular disorders, particularly in the context of diabetes.
    Type: Grant
    Filed: September 25, 2013
    Date of Patent: December 16, 2014
    Assignees: MUSC Foundation for Research Development, Department of Veterans Affairs
    Inventors: Maria F. Lopes-Virella, Gabriel T. Virella
  • Publication number: 20140093974
    Abstract: The present invention relates to the analysis of modified LDL in the context of immune complexes. In particular, ox-LDL and AGE-LDL are shown to predict the development of coronary artery disease and other micro- and macrovascular disorders, particularly in the context of diabetes.
    Type: Application
    Filed: September 25, 2013
    Publication date: April 3, 2014
    Applicants: DEPARTMENT OF VETERANS AFFAIRS, MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
    Inventors: Maria F. LOPES-VIRELLA, Gabriel T. VIRELLA
  • Patent number: 8568995
    Abstract: The present invention relates to the analysis of modified LDL in the context of immune complexes. In particular, ox-LDL and AGE-LDL are shown to predict the development of coronary artery disease and other micro- and macrovascular disorders, particularly in the context of diabetes.
    Type: Grant
    Filed: September 17, 2010
    Date of Patent: October 29, 2013
    Assignees: MUSC Foundation for Research Development, Department of Veterans Affairs
    Inventors: Maria F. Lopes-Virella, Gabriel T. Virella
  • Publication number: 20110124119
    Abstract: The present invention relates to the analysis of modified LDL in the context of immune complexes. In particular, ox-LDL and AGE-LDL are shown to predict the development of coronary artery disease and other micro- and macrovascular disorders, particularly in the context of diabetes.
    Type: Application
    Filed: September 17, 2010
    Publication date: May 26, 2011
    Inventors: Maria F. Lopes-Virella, Gabriel T. Virella